These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15567461)
21. [Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4]. Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y Ai Zheng; 2006 Feb; 25(2):163-9. PubMed ID: 16480579 [TBL] [Abstract][Full Text] [Related]
22. Gene expression profile related to prognosis of acute myeloid leukemia. Park MH; Cho SA; Yoo KH; Yang MH; Ahn JY; Lee HS; Lee KE; Mun YC; Cho DH; Seong CM; Park JH Oncol Rep; 2007 Dec; 18(6):1395-402. PubMed ID: 17982622 [TBL] [Abstract][Full Text] [Related]
23. Increased expression of Annexin A2 in oral squamous cell carcinoma. Zhong LP; Wei KJ; Yang X; Zhang L; Zhou XJ; Pan HY; Li J; Chen WT; Zhang ZY Arch Oral Biol; 2009 Jan; 54(1):17-25. PubMed ID: 18822406 [TBL] [Abstract][Full Text] [Related]
24. FUS expression alters the differentiation response to all-trans retinoic acid in NB4 and NB4R2 cells. Walsby EJ; Gilkes AF; Tonks A; Darley RL; Mills KI Br J Haematol; 2007 Oct; 139(1):94-7. PubMed ID: 17854312 [TBL] [Abstract][Full Text] [Related]
25. Membrane protein hMYADM preferentially expressed in myeloid cells is up-regulated during differentiation of stem cells and myeloid leukemia cells. Wang Q; Li N; Wang X; Shen J; Hong X; Yu H; Zhang Y; Wan T; Zhang L; Wang J; Cao X Life Sci; 2007 Jan; 80(5):420-9. PubMed ID: 17097684 [TBL] [Abstract][Full Text] [Related]
26. Annexin A2 expression during cellular differentiation in myeloid cell lines. Gilmore WS; Olwill S; McGlynn H; Alexander HD Biochem Soc Trans; 2004 Dec; 32(Pt 6):1122-3. PubMed ID: 15506985 [TBL] [Abstract][Full Text] [Related]
27. Expression of annexin II in human atherosclerotic abdominal aortic aneurysms. Hayashi T; Morishita E; Ohtake H; Oda Y; Ohta K; Arahata M; Kadohira Y; Maekawa M; Ontachi Y; Yamazaki M; Asakura H; Takami A; Nakao S Thromb Res; 2008; 123(2):274-80. PubMed ID: 18502476 [TBL] [Abstract][Full Text] [Related]
28. Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia. Tamura H; Dan K; Tamada K; Nakamura K; Shioi Y; Hyodo H; Wang SD; Dong H; Chen L; Ogata K Clin Cancer Res; 2005 Aug; 11(16):5708-17. PubMed ID: 16115907 [TBL] [Abstract][Full Text] [Related]
29. [Activity of procoagulant and fibrinolysis in homogenate of leukemic cells]. Wada H; Tanigawa M; Suzuki H; Takagi M; Mori Y; Ohno T; Kita K; Kobayashi T; Deguchi K; Shirakawa S Rinsho Ketsueki; 1989 Oct; 30(10):1783-7. PubMed ID: 2593244 [TBL] [Abstract][Full Text] [Related]
30. Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1. Petrella A; D'Acunto CW; Rodriquez M; Festa M; Tosco A; Bruno I; Terracciano S; Taddei M; Paloma LG; Parente L Eur J Cancer; 2008 Mar; 44(5):740-9. PubMed ID: 18295477 [TBL] [Abstract][Full Text] [Related]
31. Induction of apoptosis increases expression of non-canonical WNT genes in myeloid leukemia cell lines. Sercan HO; Pehlivan M; Simsek O; Ates H; Sercan Z Oncol Rep; 2007 Dec; 18(6):1563-9. PubMed ID: 17982645 [TBL] [Abstract][Full Text] [Related]
32. Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces. Tsunezumi J; Yamamoto K; Higashi S; Miyazaki K FEBS J; 2008 Oct; 275(19):4810-23. PubMed ID: 18721140 [TBL] [Abstract][Full Text] [Related]
33. [An analysis of annexin II related to HCC metastatic ability]. Dai Z; Zhou J; Li XF; Liu YK; Fan J Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):563-6. PubMed ID: 17711622 [TBL] [Abstract][Full Text] [Related]
34. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells. Hou Y; Yang L; Mou M; Hou Y; Zhang A; Pan N; Qiang R; Wei L; Zhang N Cancer Invest; 2008 Oct; 26(8):809-15. PubMed ID: 18608216 [TBL] [Abstract][Full Text] [Related]
35. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells. Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433 [TBL] [Abstract][Full Text] [Related]
36. Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia. Matsui W; Smith BD; Vala M; Beal N; Huff CA; Diehl LF; Jones RJ Br J Haematol; 2005 Mar; 128(6):853-62. PubMed ID: 15755292 [TBL] [Abstract][Full Text] [Related]
37. The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells. Rizzi M; Tschan MP; Britschgi C; Britschgi A; Hügli B; Grob TJ; Leupin N; Mueller BU; Simon HU; Ziemiecki A; Torbett BE; Fey MF; Tobler A J Leukoc Biol; 2007 Jun; 81(6):1599-608. PubMed ID: 17347302 [TBL] [Abstract][Full Text] [Related]
38. The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years. Kwaan HC; Cull EH Best Pract Res Clin Haematol; 2014 Mar; 27(1):11-8. PubMed ID: 24907013 [TBL] [Abstract][Full Text] [Related]
39. Bleeding in acute promyelocytic leukemia (APL): fibrinolysis or defibrination? Krsnik I; Escribá A; López-Rubio M; Alarcón C; del Potro E; Díaz-Mediavilla J Nouv Rev Fr Hematol (1978); 1991; 33(1):39-41. PubMed ID: 1945823 [TBL] [Abstract][Full Text] [Related]
40. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia. Kim JS; Eom JI; Cheong JW; Choi AJ; Lee JK; Yang WI; Min YH Clin Cancer Res; 2007 Feb; 13(3):1019-28. PubMed ID: 17289898 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]